InvestorsHub Logo

Amatuer17

02/11/18 9:19 AM

#2220 RE: Giovanni #2219

Possible - look at ACAD and RDHL

Most biotechs are build on promise of buyout which is based on peak revenue in future

If BO does not happen early - co needs to build the sales and marketing channels to generate revenue - most small co do not have that kind of skills and manpower - building such capability means a lot of initial costs and the anxious period of start to do actual sales - this is where the disappointments start and SP goes down